Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × Daunorubicin × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 18 Burkitt Lymphoma 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Biphenotypic, Acute 3 Myeloproliferative Disorders 2 Leukemia 2 Sarcoma, Myeloid 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Myelodysplastic Syndromes 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Basophilic, Acute 1 Hematologic Neoplasms 1 Acute Myeloid Leukemia With KMT2A Rearrangement 1

Interventions

venetoclax 20 Rituximab 13 ibrutinib 12 Cyclophosphamide 12 obinutuzumab 9 fludarabine 8 pirtobrutinib 7 zanubrutinib 6 Specimen Handling 6 Bendamustine Hydrochloride 6 Biopsy 5 fludarabine phosphate 4 acalabrutinib 4 Prednisone 4 Lenalidomide 4 Whole-Body Irradiation 3 Vincristine 3 Magnetic Resonance Spectroscopy 3 Doxorubicin 3 CT-P10 3 idelalisib 2 Surveys and Questionnaires 2 Mycophenolic Acid 2 Cyclosporine 2 Chlorambucil 2 ARQ531 2 voruciclib 1 treosulfan 1 tocilizumab 1 tislelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡